+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Radioimmunoassay"

Radioimmunoassays - Global Strategic Business Report - Product Thumbnail Image

Radioimmunoassays - Global Strategic Business Report

  • Report
  • April 2024
  • 193 Pages
  • Global
From
Global Radioimmunoassay Market 2024-2028 - Product Thumbnail Image

Global Radioimmunoassay Market 2024-2028

  • Report
  • March 2024
  • 150 Pages
  • Global
From
The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - Product Thumbnail Image

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

  • Report
  • August 2023
  • 1500 Pages
  • Global
From
From
From
Immunoassay Systems: Global Strategic Business Report - Product Thumbnail Image

Immunoassay Systems: Global Strategic Business Report

  • Report
  • April 2024
  • 267 Pages
  • Global
From
Immunodiagnostics Global Market Report 2024 - Product Thumbnail Image

Immunodiagnostics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Global Immunoassay Market 2024-2028 - Product Thumbnail Image

Global Immunoassay Market 2024-2028

  • Report
  • October 2023
  • 166 Pages
  • Global
From
Loading Indicator

Radioimmunoassay (RIA) is a laboratory technique used to measure the concentration of antigens, such as hormones, in a sample. In the context of oncology drugs, RIA is used to measure the concentration of tumor markers in the blood, which can help diagnose and monitor cancer. RIA can also be used to measure the concentration of therapeutic drugs in the blood, which can help determine the effectiveness of a drug and its dosage. RIA is a highly sensitive and specific technique, and is used in many clinical laboratories. It is also used in research laboratories to study the pharmacokinetics of drugs, and to develop new drugs. In the oncology drug market, RIA is used to measure the concentration of therapeutic drugs in the blood, and to monitor the effectiveness of the drug. It is also used to measure the concentration of tumor markers in the blood, which can help diagnose and monitor cancer. Some companies in the RIA market for oncology drugs include Abbott Laboratories, Beckman Coulter, Siemens Healthcare, and Roche Diagnostics. Show Less Read more